Healthia Past Earnings Performance
Past criteria checks 2/6
Healthia has been growing earnings at an average annual rate of 28.5%, while the Healthcare industry saw earnings declining at 6% annually. Revenues have been growing at an average rate of 35.3% per year. Healthia's return on equity is 5.4%, and it has net margins of 2.2%.
Key information
28.5%
Earnings growth rate
40.5%
EPS growth rate
| Healthcare Industry Growth | 2.4% |
| Revenue growth rate | 35.3% |
| Return on equity | 5.4% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
Revenue & Expenses Breakdown
How Healthia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 253 | 5 | 12 | 0 |
| 31 Mar 23 | 242 | 3 | 11 | 0 |
| 31 Dec 22 | 232 | 1 | 11 | 0 |
| 30 Sep 22 | 216 | -1 | 10 | 0 |
| 30 Jun 22 | 200 | -3 | 10 | 0 |
| 31 Mar 22 | 184 | -2 | 9 | 0 |
| 31 Dec 21 | 168 | 0 | 9 | 0 |
| 30 Sep 21 | 152 | 3 | 8 | 0 |
| 30 Jun 21 | 137 | 5 | 7 | 0 |
| 31 Mar 21 | 121 | 6 | 6 | 0 |
| 31 Dec 20 | 105 | 7 | 5 | 0 |
| 30 Sep 20 | 96 | 5 | 4 | 0 |
| 30 Jun 20 | 87 | 3 | 4 | 0 |
| 31 Mar 20 | 83 | 1 | 6 | 0 |
| 31 Dec 19 | 79 | 0 | 7 | 0 |
| 30 Sep 19 | 72 | 0 | 8 | 0 |
| 30 Jun 19 | 65 | -1 | 9 | 0 |
| 31 Mar 19 | 57 | -2 | 8 | 0 |
| 31 Dec 18 | 48 | -3 | 7 | 0 |
| 30 Sep 18 | 41 | -2 | 6 | 0 |
| 30 Jun 18 | 34 | -2 | 5 | 0 |
| 30 Jun 17 | 67 | 4 | 7 | 0 |
| 30 Jun 16 | 67 | 4 | 7 | 0 |
Quality Earnings: HLA has a large one-off loss of A$6.2M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: HLA became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HLA has become profitable over the past 5 years, growing earnings by 28.5% per year.
Accelerating Growth: HLA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HLA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-19.1%).
Return on Equity
High ROE: HLA's Return on Equity (5.4%) is considered low.